Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

RNA-LNP

Items 11-20 of 21

Page
per page
  1. ALC-0315
    B8595 ALC-0315
    Summary: ALC-0315 is an ionizable amino lipid that can be combined with other lipids to form lipid nanoparticles (LNP). LNP containing ALC-0315 can be utilized for the delivery of mRNA vaccines.
      ≥59.3 mg/mL
  2. ALC-0159
    B8596 ALC-0159
    Summary: ALC-0159 is a lipid excipient. ALC-0159-containing formulation have been used to develop lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines.
      ≥39.4 mg/mL
  3. 1,2-Dipalmitoyl-sn-glycero-3-PC
    C4002 1,2-Dipalmitoyl-sn-glycero-3-PC
    Summary: Liposomes assist phospholipids
      insoluble in DMSO; ≥51.6 mg/mL
  4. 1,2-Distearoyl-sn-glycero-3-PE
    C4855 1,2-Distearoyl-sn-glycero-3-PE
    Summary: Liposomes assist phospholipids
  5. 1,2-Distearoyl-sn-glycero-3-PC
    C4911 1,2-Distearoyl-sn-glycero-3-PC
    Summary: Liposomes assist phospholipids
  6. DMG-PEG 2000
    M2001 DMG-PEG 2000
     1 Citation
    Summary: PEG modified phospholipids for liposome delivery
      Soluble in DMSO
  7. DSG-PEG 2000
    M2002 DSG-PEG 2000
    Summary: PEG modified phospholipids for liposome delivery
      Soluble in DMSO
  8. DMG-PEG2000-NHS
    M2004 DMG-PEG2000-NHS
    Summary: NHS-PEG derivatives, used for liposomal delivery
      ≥49.7 mg/mL
  9. DMG-PEG2000-N3
    M2012 DMG-PEG2000-N3
    Summary: PEG modified phospholipids for liposome delivery
      ≥50.7 mg/mL
  10. Lipid 5
    M2013 Lipid 5
    Summary: A synthetic amino lipid
      insoluble in DMSO; ≥53.4 mg/mL

Items 11-20 of 21

Page
per page